Chapter 31. Adenosine Receptors as Pharmacological Targets
- 1 January 1993
- book chapter
- Published by Elsevier
- Vol. 28, 295-304
- https://doi.org/10.1016/s0065-7743(08)60901-x
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Cloning and functional characterization of a human Al adenosine receptorBiochemical and Biophysical Research Communications, 1992
- N-(1-Oxododecyl)-4.alpha.,10-dimethyl-8-aza-trans-decal-3.beta.-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclaseJournal of Medicinal Chemistry, 1992
- Molecular cloning and expression of an adenosine A2b receptor from human brainBiochemical and Biophysical Research Communications, 1992
- Molecular biology of the dopamine receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Comparative Pharmacology of Nucleoside Transport InhibitorsNucleosides and Nucleotides, 1991
- RDC8 codes for an adenosine A2 receptor with physiological constitutive activityBiochemical and Biophysical Research Communications, 1990
- Adenosinergic approaches to stroke therapeuticsMedical Hypotheses, 1990
- Effect of Adenosine Deaminase Inhibitors on the Heartʼs Functional and Biochemical Recovery from IschemiaJournal of Cardiovascular Pharmacology, 1983
- Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion.Circulation, 1982
- Quantitative thallium-201 redistribution with a fixed coronary stenosis in dogs.Circulation, 1981